drugset / Trial / NCT04962152

Naldebain and Video-assisted Thoracoscopic Surgery

NCT04962152

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the postoperative analgesic effect of combined use of Naldebain® and thoracic paravertebral block in thoracoscopic surgery

Timeline

Start
2021-07-07
Primary completion
2024-05-07
Completion
2024-05-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Dinalbuphine sebacate Small molecule 150 mg Intramuscular

Indications

No indication recorded.